drugset / Trial / NCT04232514

Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects

NCT04232514

Phase 1 Completed 28 enrolled Sunshine Lake Pharma Co., Ltd.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the drug-drug-interaction (DDI), pharmacokinetics (PK) and tolerability of HEC74647 combined with HEC110114 in healthy subjects

Timeline

Start
2020-07-15
Primary completion
2020-08-10
Completion
2020-08-22

Drugs

EvaluationDrugModalityDoseRoute
Subject HEC110114 Unknown 800 mg Oral
Subject HEC74647 Unknown 200 mg Oral